{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2Fpreclinical-testing-part-2-alzheimers-disease-june-2020-6BirbG7P","width":444,"version":"1.0","type":"rich","title":"Preclinical Testing - Part 2: Alzheimer's Disease June 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/7aa86ba2-f55f-490d-8679-5b814fcfc3cb/word-art-2020-08-31t034626-293.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3279e061-7570-4e46-979a-595786195eca\" height=\"200\" width=\"100%\" title=\"Preclinical Testing - Part 2: Alzheimer&apos;s Disease June 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!\n\nIn this episode, Naila covers papers published in June 2020 on treatment development done on animal models, targeting the cholinergic system, the glutamatergic system, synaptic function, tau, and amyloid-beta. If you are interested in this topic, you should check out our other episodes on this topic from the same month, where the approach targeted oxidative stress, inflammation, autophagy, cognitive function...\n\nEnjoy!"}